Will Voke start a new fave of e-cigarettes in 2019?
At present, the hottest vape on the market is the mini vape. So what is the next generation of e-cigarettes? Next year, will Voke lead the new trend of vapes?
As for Voke, I wonder if everyone still has an impression on it. It was the first e-cigarette to receive a UK medical product license in September 2014 and it will be launched as a non-prescription drug in the UK. It will be used in conjunction with existing nicotine replacement therapies including nicotine patches and nicotine chewing gum. It is said to be produced by British-American Tobacco.
It was originally planned to sell to the market in 2016. Later, the company behind Voke, Kind Consumer Holdings Limited, said that due to the expansion of the manufacturing process, the product will be delayed until 2019.
Voke 0.45 mg Inhaler: What is it?
To say medicine e-cigarette, this is it! This is the real medical e-cigarette!
The company’s chairman, Paul Treniman said: “Voke is expected to provide an alternative to smoking for smokers and those around them, so that it can truly reduce the health risks of smoking.”
The product looks no different from the disposable e-cigarettes that have been popular for years. But seeing the introduction, it is an amazing product! The product is provided nicotine formulations through a breathing valve in a cigarette-sized medical device, and its technology is protected by more than 340 global patents.
According to the company’s website, Voke contains 0.45 mg of nicotine. Clinical trials have shown that a dose of 0.45 mg of nicotine can effectively alleviate the smoke addiction of smokers without causing harm to the human body, and the product does not produce visible smoke. It has no smell and avoids affecting others when using.
Unfortunately, the current product has not been seen and experienced, I don’t know how this product is! I am very much looking forward to the launch of Voke!
VOKE® NICOTINE INHALER – FURTHER FUNDING WILL SUPPORT MANUFACTURING FACILITIES AND COMMERCIAL LAUNCH 15th August 2018, LONDON, UK